MRI combo spots prostate cancer treatment failure
Thursday, June 26, 2008 - 11:21
in Health & Medicine
NEW YORK (Reuters Health) - Two imaging modalities used in combination -- dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI)-MRI -- can accurately spot residual or recurrent prostate cancer in patients treated with a fairly new treatment called high-intensity focused ultrasonic ablation, a new study shows.
Read the whole article on Reuters:Science
More from Reuters:Science
Related
- MR imaging accurately determines prostate cancer treatment failureWed, 21 May 2008, 17:07:30 EDT
- CCNY researchers demonstrate effectiveness of contrast agent Cytate in detectcing prostate cancerThu, 26 Jun 2008, 10:22:16 EDT
- Molecular imaging enables earlier, individualized treatment of thyroid cancerFri, 2 Jan 2009, 11:14:59 EST
- Emerging imaging modalities impact diagnosis of digestive diseaseMon, 26 Oct 2009, 11:58:34 EDT
- Prototype breast cancer imaging system may improve patient careMon, 15 Jun 2009, 11:51:46 EDT